218 related articles for article (PubMed ID: 2715295)
1. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function.
Larrea F; Escorza A; Valero A; Hernandez L; Cravioto MC; Diaz-Sanchez V
J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295
[TBL] [Abstract][Full Text] [Related]
2. [Importance of prolactin isoforms on ovary function in hyperprolactinemic women].
Romero C; León J; Jara R; González O
Rev Chil Obstet Ginecol; 1993; 58(6):465-9. PubMed ID: 7991872
[TBL] [Abstract][Full Text] [Related]
3. Persistence of large molecular weight prolactin secretion during pregnancy in women with macroprolactinemia and its presence in fetal cord blood.
Jackson RD; Wortsman J; Malarkey WB
J Clin Endocrinol Metab; 1989 Jun; 68(6):1046-50. PubMed ID: 2723025
[TBL] [Abstract][Full Text] [Related]
4. [Prolactin variants in serum and amniotic fluid of women with ovulatory hyperprolactinemia].
Larrea F; Escorza A; Méndez I; Ruiz JE; Valero A; Cravioto MC
Rev Invest Clin; 1991; 43(3):245-51. PubMed ID: 1818370
[TBL] [Abstract][Full Text] [Related]
5. Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function.
Fraser IS; Lun ZG; Zhou JP; Herington AC; McCarron G; Caterson I; Tan K; Markham R
J Clin Endocrinol Metab; 1989 Sep; 69(3):585-92. PubMed ID: 2503534
[TBL] [Abstract][Full Text] [Related]
6. Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.
Fonseca ME; Ochoa R; Morán C; Zárate A
J Endocrinol Invest; 1991 Dec; 14(11):907-12. PubMed ID: 1806609
[TBL] [Abstract][Full Text] [Related]
7. Familial occurrence of big-big prolactin as the predominant immunoreactive human prolactin species in blood.
Larrea F; Escorza A; Granados J; Valencia X; Valero A; Cravioto MC; Pérez-Palacios G
Fertil Steril; 1987 Jun; 47(6):956-63. PubMed ID: 3595901
[TBL] [Abstract][Full Text] [Related]
8. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
Hattori N
J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses.
Jackson RD; Wortsman J; Malarkey WB
J Clin Endocrinol Metab; 1985 Aug; 61(2):258-64. PubMed ID: 4008606
[TBL] [Abstract][Full Text] [Related]
10. Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
Giusti M; Fazzuoli L; Cavallero D; Valenti S
Gynecol Endocrinol; 2002 Oct; 16(5):407-12. PubMed ID: 12587536
[TBL] [Abstract][Full Text] [Related]
11. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
12. Chromatographic pattern of circulating prolactin in ovulatory hyperprolactinemia.
Andino NA; Bidot C; Valdés M; Machado AJ
Fertil Steril; 1985 Nov; 44(5):600-5. PubMed ID: 3932101
[TBL] [Abstract][Full Text] [Related]
13. Further evidence that big,big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function.
Larrea F; Villanueva C; Carmen Cravioto M; Escorza A; del Real O
Fertil Steril; 1985 Jul; 44(1):25-30. PubMed ID: 4040038
[TBL] [Abstract][Full Text] [Related]
14. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
15. Molecular size variants of prolactin and growth hormone in mouse serum: strain differences and alterations of concentrations by physiological and pharmacological stimuli.
Sinha YN
Endocrinology; 1980 Dec; 107(6):1959-69. PubMed ID: 7428700
[TBL] [Abstract][Full Text] [Related]
16. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
Larrea F; Escorza A; Valencia X; Méndez I; Schiavon R; Forsbach G
Rev Invest Clin; 1991; 43(4):293-8. PubMed ID: 1798861
[TBL] [Abstract][Full Text] [Related]
17. Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin.
Whittaker PG; Wilcox T; Lind T
J Clin Endocrinol Metab; 1981 Oct; 53(4):863-6. PubMed ID: 7287870
[TBL] [Abstract][Full Text] [Related]
18. [Is the assessment of biological activity of prolactin essential in the diagnosis of hyperprolactinemia?].
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Pol Merkur Lekarski; 2010 May; 28(167):359-61. PubMed ID: 20568397
[TBL] [Abstract][Full Text] [Related]
19. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
20. Macroprolactin; high molecular mass forms of circulating prolactin.
Fahie-Wilson MN; John R; Ellis AR
Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]